87 related articles for article (PubMed ID: 463409)
1. [Effectiveness of adjuvant chemotherapy in ovarian carcinoma].
Krafft W; Behling H; Schirmer A; Brückmann D; Preibsch W; Kademann J; Marzotko F; Schmeisser G
Zentralbl Gynakol; 1979; 101(7):468-72. PubMed ID: 463409
[TBL] [Abstract][Full Text] [Related]
2. Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.
Trimbos JB; Vergote I; Bolis G; Vermorken JB; Mangioni C; Madronal C; Franchi M; Tateo S; Zanetta G; Scarfone G; Giurgea L; Timmers P; Coens C; Pecorelli S;
J Natl Cancer Inst; 2003 Jan; 95(2):113-25. PubMed ID: 12529344
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapeutic problems in surgically treated bronchial carcinomas (author's transl)].
Wilde J
Z Erkr Atmungsorgane; 1975 Feb; 142(2):101-9. PubMed ID: 58491
[TBL] [Abstract][Full Text] [Related]
4. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
Le T; Adolph A; Krepart GV; Lotocki R; Heywood MS
Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
[TBL] [Abstract][Full Text] [Related]
5. [Adjuvant chemotherapy in patients operated on for early ovarian carcinoma].
Trimbos JB; van der Burg ME
Ned Tijdschr Geneeskd; 2004 May; 148(18):874-8. PubMed ID: 15152388
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic trial of a combination of cytostatic agents in advanced ovarian carcinoma].
Brandl K
Zentralbl Gynakol; 1970 Feb; 92(8):233-9. PubMed ID: 5505972
[No Abstract] [Full Text] [Related]
7. [Comparison of therapeutic efficacy between TP regimen and CBP regimen on epithelial ovarian cancer after optimal cytoreductive operation].
Gao KF; Liu FY; Chen FJ; Feng YL
Ai Zheng; 2007 Apr; 26(4):431-4. PubMed ID: 17430668
[TBL] [Abstract][Full Text] [Related]
8. Compliance to clinical guidelines for early-stage epithelial ovarian cancer in relation to patient outcome.
Sijmons EA; van Lankveld MA; Witteveen PO; Peeters PH; Koot VC; van Leeuwen JS
Eur J Obstet Gynecol Reprod Biol; 2007 Apr; 131(2):203-8. PubMed ID: 16707204
[TBL] [Abstract][Full Text] [Related]
9. [Adjuvant chemotherapy in ovarian carcinoma. Preliminary results].
Velikova M; Tsvekova V; Koĭnov K
Akush Ginekol (Sofiia); 1993; 32(1):23-5. PubMed ID: 8172341
[TBL] [Abstract][Full Text] [Related]
10. Randomized trial of initial therapy with melphalan versus cisplatin-based combination chemotherapy in patients with advanced ovarian carcinoma: initial and long term results--Eastern Cooperative Oncology Group Study E2878.
Wadler S; Yeap B; Vogl S; Carbone P
Cancer; 1996 Feb; 77(4):733-42. PubMed ID: 8616766
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
12. [The problems of prophylactic chemotherapy, the second-look operation and the maintenance of the remission in the treatment of ovarian cancer (author's transl)].
Pfleiderer A
Geburtshilfe Frauenheilkd; 1976 Feb; 36(2):132-9. PubMed ID: 1254157
[TBL] [Abstract][Full Text] [Related]
13. [Combined chemo- and hormone-therapy in advanced ovarian carcinoma--theoretical, experimental foundations and clinical results].
Sevelda P
Wien Klin Wochenschr Suppl; 1990; 183():3-29. PubMed ID: 2145702
[TBL] [Abstract][Full Text] [Related]
14. [Postoperative radio- and/or chemotherapy in ovarian stage III cancers. Results of a prospective randomized study].
Richter P; Sarembe B; Lotze W
Zentralbl Gynakol; 1985; 107(4):237-44. PubMed ID: 3885634
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1.
Chambers SK; Kacinski BM; Ivins CM; Carcangiu ML
Clin Cancer Res; 1997 Jun; 3(6):999-1007. PubMed ID: 9815777
[TBL] [Abstract][Full Text] [Related]
16. [Clinical efficacy analysis of chemotherapy to lymph node metastasis in epithelial ovarian cancer].
Wu LY; Zhang R; Huang MN; Li N; Wang GX; Liu LY
Ai Zheng; 2003 Apr; 22(4):424-7. PubMed ID: 12704005
[TBL] [Abstract][Full Text] [Related]
17. Ovarian carcinosarcomas: clinicopathological prognostic factors and evaluation of chemotherapy regimens containing platinum.
Cicin I; Saip P; Eralp Y; Selam M; Topuz S; Ozluk Y; Aydin Y; Topuz E
Gynecol Oncol; 2008 Jan; 108(1):136-40. PubMed ID: 17936342
[TBL] [Abstract][Full Text] [Related]
18. [Drug therapy of ovarian carcinoma].
Dittrich C
Wien Med Wochenschr; 1996; 146(1-2):23-34. PubMed ID: 8835492
[TBL] [Abstract][Full Text] [Related]
19. Neoadjuvant chemotherapy or primary debulking surgery in advanced ovarian carcinoma: a retrospective analysis of 285 patients.
Vergote I; De Wever I; Tjalma W; Van Gramberen M; Decloedt J; van Dam P
Gynecol Oncol; 1998 Dec; 71(3):431-6. PubMed ID: 9887245
[TBL] [Abstract][Full Text] [Related]
20. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.
Akeson M; Zetterqvist BM; Dahllöf K; Brännström M; Horvath G
Acta Obstet Gynecol Scand; 2008; 87(12):1343-52. PubMed ID: 18951208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
